Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

22.01.16 | Safety of Oral Ivermectin in Children

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

14.09.15 | Xeglyze submitted for FDA approval, commercialisation deal announced

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

08.09.15 | Updated Pediculosis Pipeline insight report

DelveInsight have released an updated report covering the state of the pediculosis treatment pipeline.

28.08.15 | Eden Research license deal with TerpeneTech

Eden Research PLC has agreed a licensing deal with TerpeneTech Ltd granting exclusive use of its encapsulation technologies and other intellectual property for head lice treatments.

16.07.15 | Tyratech update: revenue and funding

Tyratech have announced increased revenues for 2014, and are focussing more of their funding on Vamousse.

22.01.16 | More Information on the Head Lice Genome

New genetic study of human head and body lice aims to clarify the relationship between the two types of lice, preparing the ground for further genome mapping.

22.01.16 | Head Lice Clinical Practice Review

A new review of lice treatments documents increasing resistance to older treatments along with promising new pediculicides.

11.01.16 | Lice infection rates in Polish schoolchildren

A new study investigating the prevalence of head lice in the villages and towns in eastern Poland has revealed interesting contrasts between infestation rates amongst girls compared to boys and between villages and towns.  

24.11.15 | Laboratory and clinical trials of cocamide lotion against head lice

A new study has revealed that cocamide DEA 10% lotion shows limited activity to eliminate head lice infection.

12.11.15 | Head lice predictors and infestation dynamics among students

Two new studies have revealed that unnoticed transmissions in schools and families are likely to be the major drivers for outbreaks of head lice infestation.

morenews-ind.png morenews-sci.png
  • Scientific News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Licecomb Engineering
  • Regulatory News
  • Company News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved